Effects of in vivo Lewy body pathology on neuropsychiatric symptoms across the Alzheimer's disease continuum

Our results suggest that in vivo-measured LB pathology is associated with a higher frequency of neuropsychiatric symptoms, with apathy, motor disturbances, appetite changes, anxiety, and psychosis as potential early neuropsychiatric manifestations of LB pathology in individuals across the AD continuum. These findings underscore the potential of in vivo LB detection as a marker for identifying individuals at elevated risk of neuropsychiatric symptoms, both in clinical trials and in clinical practice.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70857_106523
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of in vivo Lewy body pathology on neuropsychiatric symptoms across the Alzheimer's disease continuum

Dana Tudorascu, Tharick Ali Pascoal, Douglas Teixeira Leffa, Guilherme Bauer‐Negrini et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Effects of in vivo Lewy body pathology on neuropsychiatric symptoms across the Alzheimer's disease continuum

Dana Tudorascu, Tharick Ali Pascoal, Douglas Teixeira Leffa, Guilherme Bauer‐Negrini, Matheus Scarpatto Rodrigues, Arthur C. Macedo, Bruna Bellaver, Firoza Zubeida Lussier, Marina Scop Medeiros, Pamela C.L. Ferreira, Livia Amaral, Guilherme Povala, Carolina Soares, João Pedro Ferrari‐Souza, Eduardo R. Zimmer, Joseph Therriault, Pedro Rosa‐Neto
article en

Abstract

Our results suggest that in vivo-measured LB pathology is associated with a higher frequency of neuropsychiatric symptoms, with apathy, motor disturbances, appetite changes, anxiety, and psychosis as potential early neuropsychiatric manifestations of LB pathology in individuals across the AD continuum. These findings underscore the potential of in vivo LB detection as a marker for identifying individuals at elevated risk of neuropsychiatric symptoms, both in clinical trials and in clinical practice.

Alzheimer s & DementiaVol. 21(S3)
Universidade Federal do Rio Grande do Sul (BR), University of Pittsburgh (US), McGill University (CA)
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effects of in vivo Lewy body pathology on neuropsychiatric symptoms across the Alzheimer's disease continuum — Dana Tudorascu, Tharick Ali Pascoal, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS